FemPulse wins FDA IDE to use overactive bladder vaginal ring in pivotal trial
FemPulse is set to enter the pivotal clinical trial phase with its neuromodulation system to treat overactive bladder after the…
FemPulse is set to enter the pivotal clinical trial phase with its neuromodulation system to treat overactive bladder after the…
Baxter has issued a correction for its AK 98 haemodialysis machines, with the US Food and Drug Administration (FDA) classifying…
Following positive data reported earlier this year from a Phase I/II trial, Sequana Medical has touted results from a study…
EndoTheia has completed the clinical trial of its FlexStone Basket, an independently steerable device, designed for kidney stone removal. This…
Xeltis has hit two milestones for its vascular access conduit, with one coming in the regulatory arena and the other…
SonoMotion has received the US Food and Drug Administration (FDA) de novo clearance for its Stone Clear device, a non-invasive…
King Faisal Specialist Hospital & Research Centre (KFSHRC) in Saudi Arabia has entered a five-year partnership with the University of…
Astellas Pharma subsidiary, iota Biosciences, has won an investigational device exemption (IDE) from the US Food and Drug Administration (FDA)…
Diality has announced the receipt of 510(k) clearance from the US Food & Drug Administration (FDA) for its Moda-flx haemodialysis…
Texas-based medical device company VenoStent has raised $20m in Series A financing to help develop its bioabsorbable perivascular wrap, SelfWrap.…